Diabetes

Showing NaN - NaN of 45

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin aspart
  • Fresno, California
  • +68 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin glargine
  • Litchfield Park, Arizona
  • +87 more
Jan 30, 2017

Diabetes, Diabetes, Type 2 Trial in Mexico, Puerto Rico, United States (liraglutide, glimepiride, )

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +116 more
Jan 24, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin aspart, liraglutide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • +2 more
  • Concord, California
  • +123 more
Jan 20, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Little Rock, Arkansas
  • +181 more
Jan 16, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Northridge, California
  • +98 more
Jan 20, 2017

Diabetes Trial in Worldwide (Insulin sensitizer)

Completed
  • Diabetes
  • Insulin sensitizer
  • Hollywood, Florida
  • +45 more
Feb 28, 2017

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin aspart, insulin detemir)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin aspart
  • insulin detemir
  • Birmingham, Alabama
  • +66 more
Jan 2, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (repaglinide and metformin combination tablet, rosiglitazone and

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • repaglinide and metformin combination tablet
  • rosiglitazone and metformin combination tablet
  • Vestavia, Alabama
  • +102 more
Feb 9, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin glargine, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Encino, California
  • +81 more
Dec 16, 2016

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Bay Minette, Alabama
  • +186 more
Dec 16, 2016

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin NPH)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin detemir
  • insulin NPH
  • Birmingham, Alabama
  • +95 more
Jan 27, 2017

Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, pioglitazone, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +2 more
  • Birmingham, Alabama
  • +72 more
Jan 10, 2017

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (biphasic insulin aspart, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • insulin glargine
  • Birmingham, Alabama
  • +72 more
Jan 10, 2017

Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, insulin glargine, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +3 more
  • Concord, California
  • +26 more
Jan 6, 2017

Diabetes, Diabetes, Type 1 Trial in United States (insulin human, insulin lispro, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin human
  • +2 more
  • Birmingham, Alabama
  • +75 more
Dec 21, 2016

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/insulin aspart
  • insulin glargine
  • Birmingham, Alabama
  • +91 more
Oct 26, 2016

Diabetes Trial in Worldwide (Ro 205-2349)

Completed
  • Diabetes
  • Ro 205-2349
  • Huntsville, Alabama
  • +116 more
Aug 23, 2016

Diabetes Trial in Argentina, Peru, United States (Placebo, TAK-875)

Terminated
  • Diabetes
  • Birmingham, Alabama
  • +85 more
Apr 24, 2016

Diabetes Trial in Worldwide (Saxagliptin, Metformin, Placebo)

Completed
  • Diabetes
  • Concord, California
  • +210 more
Apr 8, 2015